Gland Pharma Ltd. - Research Center
543245 GLAND Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 4,167.43 | 3,616.53 | 4,400.71 | 3,462.88 | 2,633.24 |
| Expenses | |||||
| Material consumed | 1,878.50 | 1,733.32 | 2,149.33 | 1,538.17 | 1,136.27 |
| Manufacturing expenses | 117.20 | 124.84 | 95.05 | 74.59 | 78.50 |
| Personnel expenses | 409.95 | 399.70 | 338.57 | 311.36 | 277.66 |
| Selling expenses | 7.35 | 7.79 | 2.02 | 1.95 | 5.19 |
| Adminstrative expenses | 345.66 | 332.34 | 305.10 | 234.54 | 180.15 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 2,758.65 | 2,597.98 | 2,890.07 | 2,160.61 | 1,677.77 |
| Operating profit | 1,408.78 | 1,018.55 | 1,510.64 | 1,302.27 | 955.47 |
| Other recurring income | 166.67 | 240.46 | 223.94 | 134.78 | 139.17 |
| Adjusted PBDIT | 1,575.45 | 1,259.01 | 1,734.58 | 1,437.04 | 1,094.64 |
| Financial expenses | 7.84 | 7.41 | 5.24 | 3.41 | 7.18 |
| Depreciation | 162.11 | 146.74 | 110.30 | 98.78 | 94.59 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 1,405.50 | 1,104.86 | 1,619.04 | 1,334.85 | 992.87 |
| Tax charges | 362.17 | 272.58 | 406.89 | 337.85 | 220.01 |
| Adjusted PAT | 1,043.33 | 832.29 | 1,212.16 | 997.01 | 772.86 |
| Non recurring items | - | -56.46 | - | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 1,043.33 | 775.83 | 1,212.16 | 997.01 | 772.86 |
| Earnigs before appropriation | 7,054.03 | 6,010.70 | 5,234.88 | 4,022.72 | 3,025.72 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 7,054.03 | 6,010.70 | 5,234.88 | 4,022.72 | 3,025.72 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis